{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:28Z","timestamp":1740149848305,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12328-024-02025-7","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T18:07:20Z","timestamp":1723140440000},"page":"1026-1032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A small bowel adenocarcinoma harboring a DDR2 mutation in a celiac patient"],"prefix":"10.1007","volume":"17","author":[{"given":"Ludovica","family":"Mollica","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9099-5352","authenticated-orcid":false,"given":"Erica","family":"Quaquarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Schiepatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Travaglino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Antoci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Vanoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Arpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Biagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Deborah","family":"Locati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"2025_CR1","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00428-022-03393-6","volume":"481","author":"G Arpa","year":"2022","unstructured":"Arpa G, Fassan M, Guerini C, et al. Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study. Virchows Arch. 2022;481:853\u201363.","journal-title":"Virchows Arch"},{"key":"2025_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00535-019-01636-z","volume":"55","author":"AM Bouvier","year":"2020","unstructured":"Bouvier AM, Robaszkiewicz M, Jooste V, et al. Trends in incidence of small bowel cancer according to histology: a population-based study. J Gastroenterol. 2020;55:181\u20138.","journal-title":"J Gastroenterol"},{"key":"2025_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.dld.2013.04.013","volume":"46","author":"T Aparicio","year":"2014","unstructured":"Aparicio T, Zaanan A, Svrcek M, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis. 2014;46:97\u2013104.","journal-title":"Dig Liver Dis"},{"key":"2025_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/ecco-jcc\/jjx031","volume":"11","author":"A Vanoli","year":"2017","unstructured":"Vanoli A, Di Sabatino A, Furlan D, et al. Small bowel carcinomas in coeliac or Crohn\u2019s disease: clinico-pathological, molecular, and prognostic features. A study from the Small Bowel Cancer Italian Consortium. J Crohns Colitis. 2017;11:942\u201353.","journal-title":"J Crohns Colitis"},{"key":"2025_CR5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/modpathol.2017.40","volume":"30","author":"A Vanoli","year":"2017","unstructured":"Vanoli A, Di Sabatino A, Martino M, et al. Small bowel carcinomas in celiac or Crohn\u2019s disease: distinctive histophenotypic, molecular and histogenetic patterns. Mod Pathol. 2017;30:1453\u201366.","journal-title":"Mod Pathol"},{"key":"2025_CR6","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.3390\/cancers12113441","volume":"12","author":"G Neri","year":"2020","unstructured":"Neri G, Arpa G, Guerini C, et al. Small bowel adenocarcinomas featuring special AT-rich sequence-binding protein 2 (SATB2) expression and a colorectal cancer-like immunophenotype: a potential diagnostic pitfall. Cancers (Basel). 2020;12:3441.","journal-title":"Cancers (Basel)"},{"key":"2025_CR7","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41379-020-0497-0","volume":"33","author":"P Giuffrida","year":"2020","unstructured":"Giuffrida P, Arpa G, Grillo F, et al. PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability. Mod Pathol. 2020;33:1398\u2013409.","journal-title":"Mod Pathol"},{"key":"2025_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/cancers11010031","volume":"11","author":"P Giuffrida","year":"2018","unstructured":"Giuffrida P, Vanoli A, Arpa G, et al. Small bowel carcinomas associated with immune-mediated intestinal disorders: the current knowledge. Cancers (Basel). 2018;11:31.","journal-title":"Cancers (Basel)"},{"key":"2025_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.dld.2017.09.123","volume":"50","author":"C Locher","year":"2018","unstructured":"Locher C, Batumona B, Afchain P, et al. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up. Dig Liver Dis. 2018;50:15\u20139.","journal-title":"Dig Liver Dis"},{"key":"2025_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.6004\/jnccn.2019.0043","volume":"17","author":"AB Benson","year":"2019","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al. Small bowel adenocarcinoma, version 1.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:1109\u201333.","journal-title":"J Natl Compr Canc Netw"},{"key":"2025_CR11","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","volume":"3","author":"AB Schrock","year":"2017","unstructured":"Schrock AB, Devoe CE, McWilliams R, et al. Genomic profiling of small-bowel adenocarcinoma. JAMA Oncol. 2017;3:1546\u201353.","journal-title":"JAMA Oncol"},{"key":"2025_CR12","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1186\/s12885-022-09824-6","volume":"22","author":"A Tatsuguchi","year":"2022","unstructured":"Tatsuguchi A, Yamada T, Ueda K, et al. Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing. BMC Cancer. 2022;22:723.","journal-title":"BMC Cancer"},{"key":"2025_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","volume":"391","author":"B Lebwohl","year":"2018","unstructured":"Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391:70\u201381.","journal-title":"Lancet"},{"key":"2025_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nrgastro.2010.2","volume":"7","author":"F Biagi","year":"2010","unstructured":"Biagi F, Corazza GR. Mortality in celiac disease. Nat Rev Gastroenterol Hepatol. 2010;7:158\u201362.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.dld.2017.12.001","volume":"50","author":"F Biagi","year":"2018","unstructured":"Biagi F, Schiepatti A, Maiorano G, et al. Risk of complications in coeliac patients depends on age at diagnosis and type of clinical presentation. Dig Liver Dis. 2018;50:549\u201352.","journal-title":"Dig Liver Dis"},{"key":"2025_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1471-230X-14-139","volume":"14","author":"F Biagi","year":"2014","unstructured":"Biagi F, Marchese A, Ferretti F, et al. A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses. BMC Gastroenterol. 2014;14:139.","journal-title":"BMC Gastroenterol"},{"key":"2025_CR17","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1053\/j.gastro.2020.07.007","volume":"159","author":"L Emilsson","year":"2020","unstructured":"Emilsson L, Semrad C, Lebwohl B, et al. Risk of small bowel adenocarcinoma, adenomas, and carcinoids in a nationwide cohort of individuals with celiac disease. Gastroenterology. 2020;159:1686\u201394.","journal-title":"Gastroenterology"},{"key":"2025_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00428-019-02675-w","volume":"476","author":"F Rizzo","year":"2020","unstructured":"Rizzo F, Vanoli A, Sahnane N, et al. Small-bowel carcinomas associated with celiac disease: transcriptomic profiling shows predominance of microsatellite instability-immune and mesenchymal subtypes. Virchows Arch. 2020;476:711\u201323.","journal-title":"Virchows Arch"},{"key":"2025_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000519645","volume":"45","author":"X Xu","year":"2022","unstructured":"Xu X, Yu T, Wang Z. Discoidin domain receptor 2: a new target in cancer. Oncol Res Treat. 2022;45:205\u201315.","journal-title":"Oncol. Res. Treat."},{"key":"2025_CR20","doi-asserted-by":"publisher","first-page":"eaav2437","DOI":"10.1126\/sciadv.aav2437","volume":"5","author":"MM Tu","year":"2019","unstructured":"Tu MM, Lee FYF, Jones RT, et al. Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy. Sci Adv. 2019;5:eaav2437.","journal-title":"Sci Adv"},{"key":"2025_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fonc.2020.00125","volume":"10","author":"M Lafitte","year":"2020","unstructured":"Lafitte M, Sirvent A, Roche S. Collagen kinase receptors as potential therapeutic targets in metastatic colon cancer. Front Oncol. 2020;10:125.","journal-title":"Front Oncol"},{"key":"2025_CR22","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1021\/acsmedchemlett.5b00143","volume":"6","author":"CW Murray","year":"2015","unstructured":"Murray CW, Berdini V, Buck IM, et al. Fragment-based discovery of potent and selective DDR1\/2 inhibitors. ACS Med Chem Lett. 2015;6:798\u2013803.","journal-title":"ACS Med Chem Lett"},{"key":"2025_CR23","doi-asserted-by":"publisher","first-page":"E7786","DOI":"10.1073\/pnas.1805020115","volume":"115","author":"WR Grither","year":"2018","unstructured":"Grither WR, Longmore GD. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain. Proc Natl Acad Sci U S A. 2018;115:E7786\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, et al. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Sig Transduct Target Ther. 2023;8:92.","journal-title":"Sig. Transduct. Target. Ther."},{"key":"2025_CR25","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0140-6736(01)05554-4","volume":"358","author":"G Corrao","year":"2001","unstructured":"Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet. 2001;358:356\u201361.","journal-title":"Lancet"},{"key":"2025_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cgh.2011.06.029","volume":"10","author":"P Elfstr\u00f6m","year":"2012","unstructured":"Elfstr\u00f6m P, Granath F, Ye W, et al. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol. 2012;10:30\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025_CR27","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/gutjnl-2023-329751","volume":"72","author":"A Schiepatti","year":"2023","unstructured":"Schiepatti A, Maimaris S, Raju SA, et al. Persistent villous atrophy predicts development of complications and mortality in adult patients with coeliac disease: a multicentre longitudinal cohort study and development of a score to identify high-risk patients. Gut. 2023;72:2095\u2013102.","journal-title":"Gut"},{"key":"2025_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/qjmed\/hcg058","volume":"96","author":"PD Howdle","year":"2003","unstructured":"Howdle PD, Jalal PK, Holmes GK, et al. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM. 2003;96:345\u201353.","journal-title":"QJM"},{"key":"2025_CR29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/apt.16599","volume":"54","author":"A Schiepatti","year":"2021","unstructured":"Schiepatti A, Rej A, Maimaris S, et al. Clinical classification and long-term outcomes of seronegative coeliac disease: a 20-year multicentre follow-up study. Aliment Pharmacol Ther. 2021;54:1278\u201389.","journal-title":"Aliment Pharmacol Ther"},{"key":"2025_CR30","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1182\/blood-2011-10-385559","volume":"119","author":"A Di Sabatino","year":"2012","unstructured":"Di Sabatino A, Biagi F, Gobbi PG, et al. How I treat enteropathy-associated T-cell lymphoma. Blood. 2012;119:2458\u201368.","journal-title":"Blood"},{"key":"2025_CR31","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1245\/s10434-011-2173-6","volume":"19","author":"MJ Overman","year":"2012","unstructured":"Overman MJ, Hu CY, Kopetz S, et al. A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Ann Surg Oncol. 2012;19:1439\u201345.","journal-title":"Ann Surg Oncol"},{"key":"2025_CR32","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1200\/JCO.22.02833","volume":"4","author":"V Subbiah","year":"2023","unstructured":"Subbiah V, Kurzrock R. Universal germline and tumor genomic testing needed to win the war against cancer: genomics is the diagnosis. J Clin Oncol. 2023;4:3100\u20133.","journal-title":"J Clin Oncol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02025-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:23:46Z","timestamp":1731054226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02025-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02025-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,8,8]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from the patient included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}